What You Should Know:
– The Mount Sinai Hospital has achieved a significant milestone in men’s health by performing New York City’s first procedures using the HYDROS™ Robotic System.
– The technology offers a minimally invasive treatment option for benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.
Impact of BPH
BPH is a prevalent condition affecting millions of men, particularly those over 60. While non-cancerous, BPH can significantly impact quality of life, causing urinary symptoms such as frequent urination, weak stream, and nighttime urgency.
Minimally Invasive Procedure Offers Hope for Men with BPH
The HYDROS™ system represents a major advancement in BPH treatment, building upon traditional methods like transurethral resection of the prostate (TURP) and laser treatments. It offers several key innovations:
- AI-Powered Treatment Planning: The system utilizes FirstAssist AI™, an image recognition software that identifies critical anatomical structures using ultrasound, enabling personalized treatment plans tailored to each patient’s prostate anatomy.
- Advanced Visualization: HYDROS™ combines advanced ultrasound imaging with digital cystoscopy, providing surgeons with a detailed, multi-dimensional view of the prostate for enhanced precision and surgical planning.
- Robotic-Assisted Waterjet Resection: The system employs a robotic-assisted, heat-free waterjet to remove obstructive prostate tissue while preserving key anatomical structures, minimizing the risk of complications like incontinence or erectile dysfunction.
- Streamlined Workflow: HYDROS™ features an integrated tower for efficient setup, an adjustable touchscreen for improved ergonomics, and user-friendly software to guide surgeons through the procedure.
Early Success and Expanding Access
Mount Sinai urologists have successfully performed the health system’s first three HYDROS™ procedures, with all patients responding well and being discharged the following day. To expand access to this innovative technology, Mount Sinai is prioritizing training for its urology team. Dr. Kaplan, a leading urologist with extensive experience in aquablation procedures, has completed advanced HYDROS™ training and will be joined by other Mount Sinai surgeons in the coming months.